Clinical Trials on Sebaceous Hyperplasia

Total 2217 results

Boehringer Ingelheim

Completed

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.

Prostatic Hyperplasia
Marmara University

Unknown

Benign Prostatic Hyperplasia and Glycosaminoglycan

Prostatic Hyperplasia

Turkey
University Hospital of North Norway
Norwegian Cancer Society; Helse Nord

Completed

A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia (Mirena)

Endometrial Hyperplasia

Norway
GlaxoSmithKline

Completed

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Prostatic Hyperplasia

Japan
GlaxoSmithKline

Terminated

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia (FDC114785)

Prostatic Hyperplasia

Vietnam
GlaxoSmithKline

Completed

Prospective Sexual Function Study for BPH Subjects

Prostatic Hyperplasia

Germany, Australia, Netherlands, Spain, Hungary, France, Greece
John D Louie

Withdrawn

Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

Prostatic Hyperplasia

United Kingdom
GlaxoSmithKline

Completed

A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

Prostatic Hyperplasia

United States, Netherlands, Spain, Taiwan, Bulgaria, Estonia, Hungary, Italy, Belgium, Thailand, Israel, Germany, Canada, Korea, Republic of, Norway, Finland, Russian Federation, Romania, Brazil, France, Slovakia, Philippines, South... and more
GlaxoSmithKline

Completed

Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels

Prostatic Hyperplasia

United States
Boehringer Ingelheim

Completed

Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Medical University of Vienna

Completed

Women With Asymptomatic Endometrial Hyperplasia (FAME-ENDO)

Endometrial Hyperplasia

Austria
Sanofi

Completed

Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Japan
University of Messina

Completed

Genistein and Endometrial Hyperplasia

Endometrial Hyperplasia

Italy
Milkhaus Laboratory

Unknown

A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).

Prostatic Hyperplasia

United States
Peking University Third Hospital

Completed

Application of DWI in Diagnosis of Prostate Cancer

Benign Prostatic Hyperplasia | Prostate Cancer
Rennes University Hospital

Completed

Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers (CANARI)

Benign Prostate Hyperplasia

France
GlaxoSmithKline

Completed

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer

Benign Prostatic Hyperplasia | Prostate Cancer

Netherlands
GL Pharm Tech Corporation

Completed

Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS (GL2702)

Benign Prostatic Hyperplasia

Korea, Republic of
Astellas Pharma Europe B.V.

Completed

EC905 Pharmacokinetic Profile Study

Healthy | Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Phase 1

Netherlands
Turku University Hospital
University of Turku

Recruiting

Prostate Metabolism, Cancer Risk and Gut Microbiota (PROMIC)

Prostate Cancer | Prostate Hyperplasia

Finland
Mansoura University

Recruiting

The Learning Curve of Transurethral Holmium Laser Enucleation of the Prostate, Prospective Assessment

Learning Curve | Prostate Hyperplasia | Laser

Egypt
Mansoura University

Unknown

Ejaculatory Sparing Transurethral Incision Of The Prostate (ES-TUIP) Versus Conventional TUIP

Prostate Hyperplasia | Transurethral Incision Of The Prostate | Ejaculatory Dysfunction

Egypt
University of Manitoba

Not yet recruiting

Outcomes of MIST for BPH: A Single-Institution Prospective Study

Benign Prostatic Hyperplasia

Canada
IRCCS San Raffaele

Recruiting

Protocollo N 2014 - Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Italy
University of Kansas Medical Center

Recruiting

IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation

Benign Prostatic Hyperplasia

United States
Northwestern University
NorthShore University HealthSystem

Recruiting

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes

Benign Prostatic Hyperplasia

United States
Chinese University of Hong Kong

Recruiting

Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong

Benign Prostatic Hyperplasia

Hong Kong
Society of Interventional Radiology Foundation

Not yet recruiting

PROARTE -PROstate ARTery to Reduce the Symptoms of Benign Prostatic Hyperplasia (PROARTE)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia
University Hospital, Bordeaux
Bordeaux PharmacoEpi

Recruiting

Economic Evaluation of Prostatic Urethral Lift (ECOLIFT)

Benign Prostatic Hyperplasia

France
University of California, San Francisco

Completed

Questioning Patients About Adverse Medical Events

Benign Prostatic Hyperplasia

United States
Antonios Likourezos

Withdrawn

Analysis of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia Using Embosphere Microspheres

Benign Prostatic Hyperplasia

United States
ProVerum Medical

Completed

The ProVerum First in Man PROVE Study

Benign Prostatic Hyperplasia

Australia
Helwan University

Active, not recruiting

Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Egypt
Boston Scientific Corporation

Completed

Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) (REZUM)

Benign Prostatic Hyperplasia | Lower Urinary Tract Symptom

United States
IRCCS Policlinico S. Matteo

Completed

Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia (Odyliresin)

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy With Outflow Obstruction

Italy
American Medical Systems

Completed

Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)

Benign Prostatic Hyperplasia | BPH | Benign Prostatic Hypertrophy | Prostate Disease
Chang Gung Memorial Hospital

Recruiting

Longitudinal Follow-up in Women With Endometrial Hyperplasia Without Atypia

Female

Taiwan
Mansoura University

Completed

Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study

BPH

Egypt
Ferring Pharmaceuticals

Completed

Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.

BPH

Germany
University Hospital, Bordeaux

Recruiting

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction (PARTURP)

Benign Prostatic Hyperplasia

France
Changhai Hospital

Unknown

Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship

Prostatic Neoplasms | Benign Prostatic Hyperplasia | Digital Rectal Examination

China
Eli Lilly and Company

Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)

Erectile Dysfunction | Benign Prostate Hyperplasia

China
GlaxoSmithKline

Completed

Economic Analyses of the REDUCE Trial

Cancer | Benign Prostatic Hyperplasia | Neoplasms, Prostate
Nymox Corporation

Completed

Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)

Benign Prostatic Hyperplasia | BPH | LUTS | Lower Urinary Tract Symptoms (LUTS)

United States
Eli Lilly and Company

Completed

A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia (COMORBID©)

Benign Prostatic Hyperplasia | Erectile Dysfunction

United States, France, Italy, Greece, Mexico, Portugal, Canada, Germany, Russian Federation

Clinical Trials on Sebaceous Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations